Cargando…

1881. The Agency for Healthcare Research and Quality (AHRQ) Safety Program for Improving Antibiotic Use: Results From a National Antibiotic Stewardship Intervention of 402 United States (US) Hospitals

BACKGROUND: The AHRQ Safety Program for Improving Antibiotic Use aims to improve antibiotic (abx) use in acute, long-term, and outpatient care settings by enhancing abx stewardship programs (ASP) and engaging frontline providers to incorporate stewardship into daily abx decision-making, with an emph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamma, Pranita, Miller, Melissa A, Dullabh, Prashila, Ahn, Roy, Speck, Kathleen, Gao, Yue, Cosgrove, Sara E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809119/ http://dx.doi.org/10.1093/ofid/ofz359.111

Ejemplares similares

161. The Agency for Healthcare Research and Quality (AHRQ) Safety Program for Improving Antibiotic Use: Antibiotic Stewardship Intervention in 389 United States Ambulatory Practices during the COVID-19 Pandemic
por: Keller, Sara C, et al.
Publicado: (2021)

Association of a Safety Program for Improving Antibiotic Use With Antibiotic Use and Hospital-Onset Clostridioides difficile Infection Rates Among US Hospitals
por: Tamma, Pranita D., et al.
Publicado: (2021)

14. Outcomes from the AHRQ Safety Program for Improving Antibiotic Use Across 439 Long-term Care Facilities
por: Katz, Morgan, et al.
Publicado: (2020)

Implementation of an Antibiotic Stewardship Program in Long-term Care Facilities Across the US
por: Katz, Morgan J., et al.
Publicado: (2022)

Assessment of Changes in Visits and Antibiotic Prescribing During the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use and the COVID-19 Pandemic
por: Keller, Sara C., et al.
Publicado: (2022)

A framework for implementing antibiotic stewardship in ambulatory care: Lessons learned from the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use
por: Keller, Sara C., et al.
Publicado: (2022)

52. Development and Implementation of a Short Duration of Antibiotic Therapy Algorithm for Uncomplicated Gram-Negative Bacteremia
por: Bae, Esther Y, et al.
Publicado: (2020)

The Impact of Mental Health on Antibiotic Prescribing
por: Keller, Sara C., et al.
Publicado: (2022)

195. Duration of Therapy for Streptococcal Bacteremia
por: Boulos, John M, et al.
Publicado: (2021)

Understanding clinician perspectives on antibiotic associated adverse events to inform feedback
por: Cherian, Jerald, et al.
Publicado: (2023)

Prevent Antibiotic overUSE (PAUSE): Impact of a Provider Driven Antibiotic-Time out on Antibiotic Use and Prescribing
por: Thom, Kerri, et al.
Publicado: (2017)

Impact of PBP2a Assay on Antibiotic Therapy of Patients with Non-Blood, Non-Urine Staphylococcus aureus Infections
por: Shulder, Stephanie, et al.
Publicado: (2017)

Comparing the Outcomes of Adults with Enterobacteriaceae Bacteremia Receiving Short-Course vs Prolonged-Course Antibiotic Therapy
por: Chotiprasitsakul, Darunee, et al.
Publicado: (2017)

The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy
por: Chotiprasitsakul, Darunee, et al.
Publicado: (2017)

38. Predicting stenotrophomonas Maltophilia bloodstream Infections (BSI) in the Hematologic Malignancy Population
por: Karaba, Sara M, et al.
Publicado: (2020)

716 Risk Factors for Resistance to Beta-lactam/Beta-lactamase Inhibitors and Carbapenems in Bacteroides spp. Bacteremia
por: Smith, Janessa, et al.
Publicado: (2014)

203. Evaluating the Impact of Extended-Infusion Beta-Lactam Therapy on Clinical Outcomes and the Subsequent Emergence of Resistance in Adults with Gram-Negative Bloodstream Infections
por: Karaba, Sara M, et al.
Publicado: (2023)

Engaging Patients and Caregivers in a Transdisciplinary Effort to Improve Outpatient Parenteral Antimicrobial Therapy
por: Keller, Sara C, et al.
Publicado: (2020)

Reporting Extended-Spectrum β-Lactamase Positivity May Reduce Carbapenem Overuse
por: Tamma, Pranita D, et al.
Publicado: (2019)

The Role of Ertapenem for the Treatment of Complicated Intra-abdominal Infections With a Positive Culture for Enterococcus faecalis
por: Fabre, Valeria, et al.
Publicado: (2018)

1511. Effect of Discharge Antibiotic Route on Clinical Outcomes in Children with Methicillin-Resistant Staphylococcus aureus (MRSA) Osteomyelitis with Bacteremia
por: Olson, Jared, et al.
Publicado: (2019)

The Frequency of Extended-Spectrum β-Lactamase Genes Harbored by Enterobacterales Isolates at High Risk for Clinically Significant Chromosomal ampC Expression
por: Hareza, Dariusz, et al.
Publicado: (2023)

Cefiderocol Activity Against Clinical Pseudomonas aeruginosa Isolates Exhibiting Ceftolozane-Tazobactam Resistance
por: Simner, Patricia J, et al.
Publicado: (2021)

2253. Comparison of Outcomes Between Patients with and without Cystic Fibrosis Treated with Ceftolozane–Tazobactam for Pseudomonas aeruginosa Infections
por: Trisler, Michael J, et al.
Publicado: (2019)

Can the Ceftriaxone Breakpoints Be Increased Without Compromising Patient Outcomes?
por: Tamma, Pranita D, et al.
Publicado: (2018)

Clinical outcomes of seasonal influenza and pandemic influenza A (H1N1) in pediatric inpatients
por: Tamma, Pranita D, et al.
Publicado: (2010)

Survey of infectious diseases providers reveals variability in duration of antibiotic therapy for the treatment of Gram-negative bloodstream infections
por: Thaden, Joshua T., et al.
Publicado: (2022)

Single Academic Center Experience of Unrestricted β-d-Glucan Implementation
por: Fabre, Valeria, et al.
Publicado: (2018)

Comparative Effectiveness of Antibiotic Treatment Duration in Children With Pyelonephritis
por: Fox, Miriam T., et al.
Publicado: (2020)

2487. Which Extended-Spectrum β-Lactamase-Producing Enterobacterales Colonize the Gastrointestinal Tract of High-Risk Patients?
por: Stambaugh, Haley, et al.
Publicado: (2023)

Ambulatory Antibiotic Use Patterns in Bolivia: Identifying Targets for Future Antibiotic Stewardship Efforts in Latin America
por: Quirós, Rodolfo E., et al.
Publicado: (2023)

2770. Investigating the Impact of Non-CTX-M Producing ESBL-E Bloodstream Infections on Patient Outcomes
por: Hareza, Dariusz A, et al.
Publicado: (2023)

1240. Perceptions of Antimicrobial Stewardship and Antibiotic Use by Healthcare Workers in Latin America
por: Fabre, Valeria, et al.
Publicado: (2023)

Use of leading practices in US hospital antimicrobial stewardship programs
por: Stenehjem, Edward A., et al.
Publicado: (2023)

Cefepime Therapy for Cefepime-Susceptible Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bacteremia
por: Wang, Ruibin, et al.
Publicado: (2016)

Navigating treatment approaches for presumed ESBL-producing infections
por: Tamma, Pranita D, et al.
Publicado: (2021)

PRO: Testing for ESBL production is necessary for ceftriaxone-non-susceptible Enterobacterales: perfect should not be the enemy of progress
por: Tamma, Pranita D, et al.
Publicado: (2021)

Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States Hospitals
por: Goodman, Katherine E, et al.
Publicado: (2022)

Trends in pediatric community-onset Staphylococcus aureus antibiotic susceptibilities over a five-year period in a multihospital health system
por: Prochaska, Erica C., et al.
Publicado: (2023)

Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections
por: Shields, Ryan K, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o12rt5fh6v04pcnnfjkup65hkc